LIXT News and Press, Lixte Biotechnology Holdings Inc. From 11/10/25

2025-11-10 17:37:14 ET Lixte Biotechnology Holdings, Inc. (LIXT) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in LIXT stock price following earnings has averaged ±3.30% , with a median...

BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT, LIXTW), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A (PP2A), today annou...

Company underscores clinical execution and confirms advanced negotiations underway on acquisition of complementary oncology assets BOCA RATON, Fla., Oct. 16, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (N...

BOCA RATON, FL / ACCESS Newswire / September 16, 2025 / For a small-cap biotech, the headlines often center on fundraising, partnerships, or meeting exchange requirements. But every so often, the spotlight shifts to the science itself. Especially when it's the kind with the potential to rewrit...

BOCA RATON, FL / ACCESS Newswire / September 15, 2025 / For most small-cap biotechs, the summer months mean quiet trial work and the occasional conference slide deck. LIXTE Biotechnology Holdings ( NASDAQ:LIXT ) had other plans. Since June 2025, the company has rewritten its playbook, refreshi...

2025-09-12 09:21:05 ET DENVER, Colo., Sep 12, 2025 ( 247marketnews.com )-  Wall Street is waking up to a red-hot biotech blitz this morning, here’s your top-of-the-morning rundown: Yesterday’s market star, LIXTE (NASDAQ:LIXT) , is again in the spotlight after ...

2025-09-11 15:33:27 ET DENVER, Colo., Sep 11, 2025 ( 247marketnews.com )- As the final hour of trading approaches, market action is heating up for a handful of small- and mid-cap stocks are lighting up the tape with bold pivots, breakouts, and breakout potential . Today’s...

2025-09-10 16:17:08 ET More on Lixte Biotechnology Holdings, Inc. Lixte Biotechnology announces $5M equity financing; shares down Financial information for Lixte Biotechnology Holdings, Inc. Read the full article on Seeking Alpha For further details see: ...

BOCA RATON, Fla., Sept. 10, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) ( Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced it has made an initial purchase of cryptocurrencies to furt...

2025-09-10 12:59:40 ET DENVER, Colo., Sep 10, 2025 ( 247marketnews.com )- Lixte Biotechnology (NASDAQ:LIXT) is attracting investor attention as bullish sentiment builds around its lead compound LB‑100, a first-in-class Protein Phosphatase 2A (PP2A) inhibitor dubbed a “...